Abstract
Safety and efficacy of repeat ivermectin mass drug administrations for malaria control (RIMDAMAL II): a phase 3, double-blind, placebo-controlled, cluster-randomised, parallel-group trial.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have